From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA reviews the use of progression-free survival in cancer trials

from Medscape Medical News

A faster, less expensive method of verifying progression-free survival data in cancer drug clinical trials is being considered by the U.S. Food and Drug Administration. But the potential change in methodology is seen as a threat to quality data by a number of experts. The matter was debated at an unusual meeting of the FDA Oncologic Drugs Advisory Committee. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063